Clinical Report: Parents’ Views on Urine GIP Testing in Children With Coeliac Disease

Overview

This single-centre qualitative study used semi-structured group interviews with 10 parents whose children had previously participated in urine gluten immunogenic peptide (GIP) research. Parents described practical and emotional barriers to urine collection, but expressed interest in periodic home-based point-of-care testing, particularly during dietary training or after suspected gluten exposure. The authors identify child-friendly test design, clearer educational materials and direct inclusion of children’s perspectives as priorities for future work.

Background

Coeliac disease is an immune-mediated enteropathy triggered by gluten in genetically susceptible individuals, and affects approximately 0.5%–1% of the global population. A strict lifelong gluten-free diet is the sole effective treatment, but mucosal recovery may take up to 2 years in children; ongoing gluten exposure can contribute to symptoms and mucosal injury. Urinary GIPs can provide an objective measure of recent gluten exposure, with research indicating detection of dietary transgressions within 24 hours. However, the article reports that clinical guidelines have cautioned against routine use because evidence is insufficient and patient perspectives have not been incorporated.

Data Highlights

Key Findings

• Parents reported practical and emotional obstacles to collecting urine samples for GIP measurement.
• The clinical environment affected children’s emotional states during urine collection; embarrassment and environmental stress were among the secondary themes.
• Some parents were confused by sampling instructions, indicating a need for clearer guidance.
• Despite these barriers, parents expressed strong interest in periodic home-based GIP point-of-care testing, particularly during dietary training or after suspected gluten exposure.
• The study authors conclude that parents viewed GIP point-of-care testing as a potential adjunct to childhood coeliac disease management when combined with education and supportive care.
• The authors call for child-friendly test design, user-centred educational materials and research that includes children’s direct perspectives.

Clinical Implications

The study supports considering parental perspectives when evaluating possible GIP point-of-care testing in paediatric coeliac disease, while its qualitative design does not establish clinical effectiveness or justify routine use. The authors identify clearer sampling instructions, supportive clinical interactions and direct inclusion of children in future research as areas for attention.

Conclusion

Parents in this small qualitative study reported both challenges with urine GIP sampling and interest in periodic home testing. Further work should address usability and education and incorporate children’s perspectives, as the authors recommend.

Related Resources & Content

1. Study authors not provided, Journal/source not provided, Year not provided -- Parents’ views on urine testing for gluten immunogenic peptides in children with coeliac disease: a qualitative study of barriers, emotional responses and interest in point-of-care testing
2. European Society for the Study of Coeliac Disease, Amsterdam UMC, 2025 -- European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow-Up, and Complex Disease Courses
3. Authors not provided, PubMed, 2024 -- Stool Gluten Peptide Detection Is Superior to Urinary Analysis, Coeliac Serology, Dietary Adherence Scores and Symptoms in the Detection of Intermittent Gluten Exposure in Coeliac Disease: A Randomised, Placebo-Controlled, Low-Dose Gluten Challenge Study
4. Authors not provided, PubMed, 2025 -- Comparative Effectiveness of Urine vs. Stool Gluten Immunogenic Peptides Testing for Monitoring Gluten Intake in Coeliac Patients: A Systematic Review and Meta-Analysis
5. Journal of Gastroenterology — Detecting Celiac Disease in Asymptomatic Pediatric Patients: Insights from the Generation R Study
6. The New Gastroenterologist — Increased Serological Markers Alone Do Not Confirm Celiac Disease Diagnosis
7. the pathologist — Celiac Screening
8. The Journal of Clinical Endocrinology & Metabolism — User Satisfaction with Continuous Glucose Monitoring for Congenital Hyperinsulinism: A Nationwide Survey in the UK
9. European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow-Up, and Complex Disease Courses
10. Stool Gluten Peptide Detection Is Superior to Urinary Analysis, Coeliac Serology, Dietary Adherence Scores and Symptoms in the Detection of Intermittent Gluten Exposure in Coeliac Disease
11. Comparative Effectiveness of Urine vs. Stool Gluten Immunogenic Peptides Testing for Monitoring Gluten Intake in Coeliac Patients: A Systematic Review and Meta-Analysis
12. Stool Gluten Peptide Detection Is Superior to Urinary Analysis, Coeliac Serology, Dietary Adherence Scores and Symptoms in the Detection of Intermittent Gluten Exposure in Coeliac Disease: A Randomised, Placebo-Controlled, Low-Dose Gluten Challenge Study - PubMed
13. Comparative Effectiveness of Urine vs. Stool Gluten Immunogenic Peptides Testing for Monitoring Gluten Intake in Coeliac Patients: A Systematic Review and Meta-Analysis.